Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $29.6B
1-Year Est. Return 20.82%
This Quarter Est. Return
1 Year Est. Return
+20.82%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$29.6B
AUM Growth
+$2.54B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,389
New
Increased
Reduced
Closed

Top Buys

1 +$175M
2 +$137M
3 +$137M
4
MSFT icon
Microsoft
MSFT
+$116M
5
NFLX icon
Netflix
NFLX
+$113M

Top Sells

1 +$134M
2 +$125M
3 +$96.7M
4
WELL icon
Welltower
WELL
+$79.1M
5
MAA icon
Mid-America Apartment Communities
MAA
+$74.6M

Sector Composition

1 Technology 30.01%
2 Real Estate 28.67%
3 Communication Services 10.86%
4 Consumer Discretionary 6.91%
5 Financials 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELVN icon
1226
Enliven Therapeutics
ELVN
$1.59B
$3K ﹤0.01%
152
FTRE icon
1227
Fortrea Holdings
FTRE
$1.52B
$3K ﹤0.01%
328
GERN icon
1228
Geron
GERN
$836M
$3K ﹤0.01%
2,247
KURA icon
1229
Kura Oncology
KURA
$736M
$3K ﹤0.01%
297
MGTX icon
1230
MeiraGTx Holdings
MGTX
$597M
$3K ﹤0.01%
330
DFTX
1231
Definium Therapeutics, Inc. Common Shares
DFTX
$1.48B
$3K ﹤0.01%
242
ORIC icon
1232
Oric Pharmaceuticals
ORIC
$1.18B
$3K ﹤0.01%
249
PHAT icon
1233
Phathom Pharmaceuticals
PHAT
$1.1B
$3K ﹤0.01%
260
PRAX icon
1234
Praxis Precision Medicines
PRAX
$8.8B
$3K ﹤0.01%
62
PSNL icon
1235
Personalis
PSNL
$878M
$3K ﹤0.01%
400
RLAY icon
1236
Relay Therapeutics
RLAY
$1.27B
$3K ﹤0.01%
486
SANA icon
1237
Sana Biotechnology
SANA
$1.22B
$3K ﹤0.01%
767
SYRE icon
1238
Spyre Therapeutics
SYRE
$2.58B
$3K ﹤0.01%
206
TBPH icon
1239
Theravance Biopharma
TBPH
$1.01B
$3K ﹤0.01%
215
TNGX icon
1240
Tango Therapeutics
TNGX
$1.75B
$3K ﹤0.01%
355
TRVI icon
1241
Trevi Therapeutics
TRVI
$1.34B
$3K ﹤0.01%
305
URGN icon
1242
UroGen Pharma
URGN
$880M
$3K ﹤0.01%
160
XERS icon
1243
Xeris Biopharma Holdings
XERS
$1.25B
$3K ﹤0.01%
404
XNCR icon
1244
Xencor
XNCR
$913M
$3K ﹤0.01%
222
EYPT icon
1245
EyePoint Inc
EYPT
$1.25B
$2K ﹤0.01%
144
FDMT icon
1246
4D Molecular Therapeutics
FDMT
$431M
$2K ﹤0.01%
184
GLPG icon
1247
Galapagos
GLPG
$2.21B
$2K ﹤0.01%
51
GLUE icon
1248
Monte Rosa Therapeutics
GLUE
$1.81B
$2K ﹤0.01%
203
PGEN icon
1249
Precigen
PGEN
$1.56B
$2K ﹤0.01%
708
PRME icon
1250
Prime Medicine
PRME
$718M
$2K ﹤0.01%
398